Patent · US Active

Inhibitors of human immunodeficiency virus replication

US10221129B2 · kind B2 · utility

0Cited by

2References

20Claims

0Family size

Assignee

ViiV Healthcare UK (No.5) Limited · GB

Inventors

John A. Bender · Middletown, US
Robert G. Gentles · Killingworth, US
Annapurna Pendri · South Glastonbury, US
Alan Xiangdong Wang · Guilford, US
Nicholas A. Meanwell · East Hampton, US
Brett R. Beno · Cromwell, US
Robert A. Fridell · Wallingford, US
Makonen Belema · North Haven, US
Van N. Nguyen · West Haven, US
Zhong Yang · Middletown, US
Gan Wang · Wallingford, US
Selvakumar Kumaravel · Bengaluru, IN
Srinivasan Thangathirupathy · Hosur, IN
Rajesh Onkardas Bora · Bengaluru, IN
Shilpa Maheshwarappa Holehatti · Bengaluru, IN
Mallikarjuna Rao Mettu · Bengaluru, IN
Manoranjan Panda · Survanagiri, IN

Key dates

Filing date	Apr 22, 2016
Grant date	Mar 5, 2019
Priority date	—
Expiry date	Apr 22, 2036

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07C2602/08
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Compounds of Formula I, including pharmaceutically acceptable salts thereof, and compositions and methods for treating human immunodeficiency virus (HIV) infection are set forth:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.